Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome.

Dahl A, Rasmussen RV, Bundgaard H, Hassager C, Bruun LE, Lauridsen TK, Moser C, Sogaard P, Arpi M, Bruun NE.

Circulation. 2013 Apr 30;127(17):1810-7. doi: 10.1161/CIRCULATIONAHA.112.001170. Epub 2013 Mar 29.

PMID:
23543002
[PubMed - indexed for MEDLINE]
Free Article
2.

[Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].

Pişkin N, Akduman D, Aydemir H, Celebi G, Oztoprak N, Aktaş E.

Mikrobiyol Bul. 2008 Jul;42(3):509-14. Turkish.

PMID:
18822897
[PubMed - indexed for MEDLINE]
3.

Porcine-origin gentamicin-resistant Enterococcus faecalis in humans, Denmark.

Larsen J, Schønheyder HC, Lester CH, Olsen SS, Porsbo LJ, Garcia-Migura L, Jensen LB, Bisgaard M, Hammerum AM.

Emerg Infect Dis. 2010 Apr;16(4):682-4. doi: 10.3201/eid1604.090500.

PMID:
20350387
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Single center experience of a vancomycin resistant enterococcal endocarditis cohort.

Forrest GN, Arnold RS, Gammie JS, Gilliam BL.

J Infect. 2011 Dec;63(6):420-8. doi: 10.1016/j.jinf.2011.08.014. Epub 2011 Sep 6.

PMID:
21920382
[PubMed - indexed for MEDLINE]
5.

Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.

Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A.

Clin Infect Dis. 2013 May;56(9):1261-8. doi: 10.1093/cid/cit052. Epub 2013 Feb 7.

PMID:
23392394
[PubMed - indexed for MEDLINE]
Free Article
6.

Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients.

Buchholtz K, Larsen CT, Hassager C, Bruun NE.

Clin Infect Dis. 2009 Jan 1;48(1):65-71. doi: 10.1086/594122.

PMID:
19046065
[PubMed - indexed for MEDLINE]
Free Article
7.

Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used?

Olaison L, Schadewitz K; Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis.

Clin Infect Dis. 2002 Jan 15;34(2):159-66. Epub 2001 Dec 7.

PMID:
11740702
[PubMed - indexed for MEDLINE]
Free Article
8.

Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.

Ramos MC, Grayson ML, Eliopoulos GM, Bayer AS.

Antimicrob Agents Chemother. 1992 Sep;36(9):1864-9.

PMID:
1329632
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.

Gavaldà J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, Crespo E, Pigrau C, Pahissa A.

Antimicrob Agents Chemother. 1996 Jan;40(1):173-8.

PMID:
8787901
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome.

Fernández Guerrero ML, Goyenechea A, Verdejo C, Roblas RF, de Górgolas M.

Medicine (Baltimore). 2007 Nov;86(6):363-77.

PMID:
18004181
[PubMed - indexed for MEDLINE]
11.

Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.

Rehm SJ, Boucher H, Levine D, Campion M, Eisenstein BI, Vigliani GA, Corey GR, Abrutyn E.

J Antimicrob Chemother. 2008 Dec;62(6):1413-21. doi: 10.1093/jac/dkn372. Epub 2008 Sep 8.

PMID:
18782781
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study.

Anderson DJ, Murdoch DR, Sexton DJ, Reller LB, Stout JE, Cabell CH, Corey GR.

Infection. 2004 Apr;32(2):72-7.

PMID:
15057570
[PubMed - indexed for MEDLINE]
13.

The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.

Dubé L, Caillon J, Jacqueline C, Bugnon D, Potel G, Asseray N.

Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2545-7. Epub 2012 Mar 8.

PMID:
22395262
[PubMed - indexed for MEDLINE]
14.

[Enterococcal endocarditis: a multicenter study of 76 cases].

Martínez-Marcos FJ, Lomas-Cabezas JM, Hidalgo-Tenorio C, de la Torre-Lima J, Plata-Ciézar A, Reguera-Iglesias JM, Ruiz-Morales J, Márquez-Solero M, Gálvez-Acebal J, de Alarcón-González A; Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas.

Enferm Infecc Microbiol Clin. 2009 Dec;27(10):571-9. doi: 10.1016/j.eimc.2009.02.007. Epub 2009 May 24. Spanish.

PMID:
19477041
[PubMed - indexed for MEDLINE]
15.

Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.

Chirouze C, Athan E, Alla F, Chu VH, Ralph Corey G, Selton-Suty C, Erpelding ML, Miro JM, Olaison L, Hoen B; International Collaboration on Endocarditis Study Group.

Clin Microbiol Infect. 2013 Dec;19(12):1140-7. doi: 10.1111/1469-0691.12166. Epub 2013 Mar 20.

PMID:
23517406
[PubMed - indexed for MEDLINE]
16.

Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.

Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A.

J Antimicrob Chemother. 2003 Sep;52(3):514-7. Epub 2003 Aug 13.

PMID:
12917251
[PubMed - indexed for MEDLINE]
Free Article
17.

Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.

López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A.

Antimicrob Agents Chemother. 2001 May;45(5):1387-93.

PMID:
11302800
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Enterococcal infective endocarditis: description of 12 cases].

Martínez Odriozola P, Muñoz Sánchez J, Arriola Martínez P, Lizarralde Palacios E, Santamaría Jáuregui JM, Zuazo Meabe J, Cisterna Cáncer R, de la Villa FM.

An Med Interna. 2007 Nov;24(11):539-42. Spanish.

PMID:
18275263
[PubMed - indexed for MEDLINE]
19.

Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.

Lavoie SR, Wong ES, Coudron PE, Williams DS, Markowitz SM.

Antimicrob Agents Chemother. 1993 Jul;37(7):1447-51.

PMID:
8363374
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and review.

Tam VH, Mckinnon PS, Levine DP, Brandel SM, Rybak MJ.

Pharmacotherapy. 2000 Sep;20(9):1116-9.

PMID:
10999505
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk